Mubadala

Certara

Certara accelerates medicines using its proprietary biosimulation software and technology to transform traditional drug discovery and development.

Certara accelerates medicines using its proprietary biosimulation software and technology to transform traditional drug discovery and development.

Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries.

Since 2014, Certara’s customers, who use its software and technology-driven services, have received 90% of novel drug approvals by the US FDA.

Other Pharmaceutical & Medical Technology Assets

  • Alloy Therapeutics

    Alloy is a biotechnology company that is developing and commercializing drug discovery platforms and services

    Read more
  • Ansa Biotechnologies

    Ansa is a synthetic biology company whose mission is to develop automated technology to synthesize strands of DNA in a fast, reliable and non-toxic matter.

    Read more
  • Ciitizen

    Ciitizen is a clinical trial patient recruitment platform that takes a patient-centric approach (versus provider/payer/pharma-centric) to establish a high-quality double-sided marketplace for matching patients and trials.

    Read more
  • Collective Health

    Collective Health (“CH”) is an enterprise software company building an end-to-end self-insurance platform to help employers process, manage and analyze health benefits.

    Read more
  • Outset Medical

    Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.

    Read more
  • Datavant

    Datavant's mission is to connect the world's health data to improve patient outcomes.

    Read more